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Background: The diseases caused by avian leukosis virus subgroup J (ALV-J) has become a serious problem in the
poultry. Due to largely ineffective vaccines, new control measures are needed to be developed. RNA interference
(RNAi) has been developed a promising measure for antivirus in poultry.
Methods: In this study, miRNA-embedded siRNA interference was designed and used to inhibit ALV-J replication
in vitro and in vivo. Each sequence of target siRNA derived from the gag (p15), pol (p32), env (gp85) and LTR (U3)
gene of ALV-J was embedded into mouse miR-155 backbone as a pre-miRNA hairpin oligonucleotide sequence.
After annealing, they were cloned into pcDNA6.2-GW/EmGFP-miR vector, respectively. For detecting the interference
effect, recombinant vectors were introduced into DF-1 cells and day-old SPF chickens that infected with ALV-J.
Results: In vitro, single target interference showed effective inhibition of reducing 74% ~ 85% mRNA of ALV-J.
Double targets showed more efficient inhibition of reducing 96% ~ 98% mRNA of ALV-J. In vivo, chicks were
inoculated with each recombinant plasmid in peritoneal cavity at day of hatch, and monitored infection status at
interval 1 day postinfection for 4 weeks. Delivery of single target or double targets miRNA significantly reduced
viremia and pathogenicity caused by ALV-J in vivo, especially the double targets.
Conclusions: These data demonstrated that the miRNA-embedded siRNA interference is an efficient method for
inhibition of ALV-J replication, especially double targets.
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Avian leukosis virus subgroup J (ALV-J), an oncogenic
retrovirus, isolated in the United Kingdom in 1991, has
been spread primarily in meat-type chickens and later in
egg-type chickens [1-5]. During the past twenty years,
ALV-J has emerged as a serious cause of mortality and
suboptimal performance in domestic chickens. Signifi-
cant economic losses caused by ALV-J infection can be
associated with immunosuppression, weight loss and
myeloid leukosis formation. The transmission of ALV-J
is much higher than other ALV subgroups [6], and some
birds show immunological tolerance against the virus,
thus making control and eradication much more difficult.* Correspondence: czqsd@126.com
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unless otherwise stated.Due to vaccines are largely ineffective, new measures
against ALV-J are needed to be developed. RNA interfer-
ence (RNAi) has shown a promising antiviral strategy in
poultry [7-10].
RNAi regulate posttranscriptional gene using small RNAs
produced through multicomplex machinery to guide sup-
pression of complementary transcripts. In general, short
hairpin RNAs (shRNAs) shows more efficient than small
interfering RNAs (siRNAs) for transient gene knockdown
[11,12]. Simple stem-loop shRNAs transcribed from Pol-III
promoters enter the processing machinery at the level of
Dicer and can be effective RNAi triggers. Several cases
showed successes in interference of ALV replication by
using shRNA. Hu et al. [13] showed that siRNAs containing
sequences of the gag gene of avian leukosis virus (ALV),
when electroporated into chicken embryos, were effective
at slowing viral propagation. Chen et al. [14] demonstratedis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sequence or the viral env (B) sequence significantly inhib-
ited ALV-B replication. Meng et al. [15] also demonstrated
that the gag target was shown to effectively suppress the
replication of ALV-J by 19.0–77.3%. Though above data
showed effective interference virus replication by shRNA,
however, their enforced expression can saturate endogen-
ous microRNA (miRNA) pathways and result in severe tox-
icities [16]. Moreover, Gu et al. [17] revealed that Dicer is
imprecise in processing commonly used simple stem-loop
designs, which increases the likelihood of aberrant guide-
and passenger-strand mediated off-target effects.
MicroRNAs (miRNAs) are endogenous substrates
for the RNAi machinery. They are initially expressed
as ~80 nt long RNA hairpin located within polymerase
II (pol II)-derived transcripts referred to as primary tran-
scripts (pri-miRNAs), which are processed within the
nucleus into ~60 nt precursor miRNA (pre-miRNA)
hairpins by the RNase III enzyme Drosha and its cofac-
tor DGCR8 [18,19]. The loop is removed by further pro-
cessing in the cytoplasm by another RNase III enzyme
Dicer and its cofactor TRBP, yielding an RNA duplex of
~20 bp flanked by 2-nt 3′ overhangs. The RNA strand is
loaded into the RNA-induced silencing complex (RISC)
and forms the mature miRNA [20,21]. The miRNA then
guides RISC to mRNAs bearing complementary target
sites [22].
Base on endogenous miRNA biogenesis pathways, a
novel approach established with introducing synthetic
shRNA stems into the context of endogenous miRNAs
can trigger potent knockdown. A number of miRNA
backbones can be used, including miR-155, miR-30 and
miR17-92 [23-25].
In this study, we screened the optimal sequence of tar-
get siRNA in gag, pol, env and LTR of ALV-J genome
for RNAi ALV-J replication. The siRNA was embedded
into mouse miR-155 backbone to form pre-miRNA hair-
pin structure, and then constructed into pcDNA6.2-
GW/EmGFP-miR vector. After transfection assay, ALV-J
infected DF-1 cells were transfected or day old SPF
chicks were inoculated with single target or double tar-
gets recombinant vectors. Quantitative real time PCR
(qPCR), western blot and immunofluorescence assays
(IFA) were used to detect interference effect in vitro,
and infection status and pathogenicity were evaluated
for interference effect in vivo.
Results
Construction of expression vectors and its transfection
efficiency
The synthesis of four pre-miRNA (schematic diagram
was shown in Figure 1) and a control sequence was
cloned into pcDNA6.2-GW/EmGFP-miR, respectively,
and named p-miR-gag, p-miR-pol, p-miR-env, p-miR-LTR and null vector control. Sequence analysis and re-
combinant plasmid electrophoresis results confirmed
that miRNA-embedded siRNA expression vectors were
successfully constructed. At 48 h post transfection, typical
green fluorescence-positive cells were observed by fluores-
cence microscopy. As shown in Figure 2, about 70% of the
DF-1 cells are positive, indicating the transfection efficien-
cies is suitable for RNA interference experiment.
MiRNA-embedded siRNA interference of single target
and double targets significantly inhibit ALV-J replication
in vitro
To assess the corresponding effects on ALV-J replication,
we used each recombinant expression vector to transfect
DF-1 cells that infected NX0101 strain of ALV-J. To assess
the co-interference effect on ALV-J replication, we used
non-coding sequence-LTR combining with other three
construct gene (gag, pol and env) to set up three com-
bined groups (gag + LTR, pol + LTR and env + LTR). The
combined plasmids were transfected into DF-1 cells that
infected with ALV-J. At 72 h post-transfection, the effect
of the anti-ALV-J vectors on viral infection was measured
by immunofluorescence, western blot and qPCR.
As shown in Figures 3 and 4, IFA and western blot re-
sults indicated that four recombinant plasmids were all
significantly reduced fluorescence intensity compared
with ALV-J control, indicating that the significant inhib-
ition of the expression of the ALV-J target gene. All
combined recombinant plasmids were significantly re-
duced expression of ALV-J compared with null control
and ALV-J control. No significant differences were de-
tected among the ALV-J control and null vector control.
The qPCR analysis for env gene expression of ALV-J
showed that mRNA levels in cells transfected with four
single-targets and three double-targets differed signifi-
cantly from that observed in the ALV-J control and null
vector control groups (P < 0.05) (Figure 5). All four re-
combinant vectors, p-miR-gag, p-miR-pol, p-miR-env and
p-miR-LTR, induced a considerable reduction in viral
mRNA copies of 83%, 78%, 85% and 74%, respectively.
The interference efficiency of three double-targets for
mRNA level of ALV-J is 98%, 98%, and 96%, respectively.
Single-targets and double-targets showed significantly dif-
ference (P < 0.05). No significant differences were detected
among the ALV-J control and null vector control.
MiRNA-embedded siRNA interference significantly reduce
viremia and pathogenicity caused by ALV-J
The anti-virus efficacies of the miRNA-embedded siRNA
interference were determined by infection status tested by
ELISA for ALV-J antigen and antibody (viremia), leukocyte
count, and histopathology observation (pathogenicity) in
chickens experimentally inoculated with ALV-J and re-
combinant plasmids.
Figure 1 The forward and reverse sequence of pre-miRNA containing target siRNA (A) and the hairpin structures of miRNA-embedded
siRNA (B).
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Table 1. ALV-J control and null control was continuous
shedding virus from day 2. Single target interference
group showed no shedding until 8 days for pol target,
10 days for LTR target, 12 days for gag tatget, and
16 days for env target post infection of ALV-J. Consist-
ent with in vitro result, single target of env was found to
be the most effective plasmid that postpones the time of
shedding virus to 16 days compared to other single tar-
get interference groups. Double-target groups showed
more protective efficiency compared to single target
groups. They can postpone the time of shedding virus
from 16 to 22 days. Though shedding virus in interfer-
ence groups at last, the level of shedding virus was sig-
nificant lower (p < 0.05) than positive control group,
indicating that all interference plasmid can effectively re-
duce the levels of ALV-J in vivo.
Histopathological analysis at 14 days post infection
showed that obvious foci of inflammatory filtration was
present in various tissues of ALV-J infected and null
control group, while no any invisible lesions was observedFigure 2 Transfection effect of recombinant expression vectors
observed by fluorescence microscope. The miRNA-embedded
siRNA expression plasmids were transfected into DF-1 cells and GFP
expression was monitored at 48 h post-transfection by fluorescence
microscopy (magnification 40×).in RNAi groups. At 28 days post infection, in ALV-J and
null control group, more serious lesions were developed,
while in RNAi group, only mild inflammatory filtration
was observed (data not shown).
Overall, viremia or pathogenicity in both the single
and double target groups were postponed or reduced
compared to the positive control groups, suggesting
that the expression of anti-ALV-J miRNA-embedded
siRNA was able to decrease replication of pathogenic
ALV-J in chickens.
Discussion
The power of RNAi to silence specific genes is now
widely used in the laboratory to explore the functions of
genes. RNAi generally arises from two types of inter-
mediary molecules: micro-RNAs (miRNAs) and small
interfering RNAs (siRNAs). Both siRNA and miRNA can
stop production of specific proteins by triggering deg-
radation of specific mRNAs. However, due to its simple
short-hairpin, the interference efficiency of siRNA is less
than miRNA. miRNA genes transcribed as larger “pri-
miRNA” precursors have been found to more effectively
generate an RNAi effect. In this case, we designed to re-
place the stem region of a miRNA gene with the target
viral siRNA sequence and its guide RNA complement,
namely, constructing a pri-miRNA containing target
viral siRNA, and then to test the interference efficiency.
The results demonstrated that the method of miRNA
embedded siRNA is widely effective for any genes in
ALV-J at inhibiting viral replication, and the interference
efficiency is higher than previous report regardless of
any single target. For getting higher interference effi-
ciency, we used double targets to co-transfect DF-1 cells
that infected by ALV-J. Since ALV-J comprise of three
constructive genes of gag, pol and env, and two non-
coding genes of LTR. So, we designed LTR combining
with other three constructive genes. The RNAi result
Figure 3 Single target and double target interference efficiency detected by IFA. The 200 ng single target miRNA-embedded siRNA
expression plasmids and p-miR-LTR (100 ng) combination with p-miR-gag (100 ng), p-miR-pol (100 ng) and p-miR-env (100 ng) were transfected
with ALV-J into DF-1 cells and gp85 protein of ALV-J expression was monitored 72 h post-transfection by fluorescence microscopy (magnification
40×). The primary antibody is anti-gp85 monoclonal antibody (1D4), and the second antibody is PE-labeled anti-mouse antibody.
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creased ALV-J mRNA copies in cultured cells, suggesting
that double target of miRNA embedded siRNA is more
efficient method for inhibition of ALV-J replication and
possible for application of clinical practice.
Comparing simple stem-loop, the pre-miRNA (miRNA-
embedded siRNA) which has double loops has several ad-
vantages: (1) like endogenous miRNAs, miRNA-embeddedFigure 4 Western blot detection of ALV-J expression. (A) Single
target RNAi; (B) double targets RNAi.siRNA can be expressed more efficiently and higher inter-
ference efficiency [18,19]; (2) multiple miRNA-embedded
siRNA can be expressed as a polycistron, providing a
setup for combinatorial RNAi studies [23,26]; (3) miRNA-
embedded siRNA are less prone to cause toxicities by
interfering with endogenous miRNA pathways [27];
(4) the natural loop configuration of miRNA-embedded
siRNA ensures precise Dicer cleavage and reduces off-
target effects [17].
Furthermore, a major concern for the miRNA embed-
ded siRNA is the possibility of clinical application. So, we
singlely or doubly delivered plasmids into body cavity of
day-old chicks by injection. For getting obvious results, we
took high dose of 105.2 TCID50 ALV-J and Lipofectamin
2000 coated recombinant plasmids. The results demon-
strated that the plasmid containing miRNA embedded
siRNA can significantly reduce ALV-J viremia and patho-
genicity, especially in double-target RNAi groups, al-
though it could not completely inhibit ALV-J replication.
The incomplete inhibition could be due to the high dose
of ALV-J, the administration route of recombinant plas-
mids, or the vectors and so on. The apparent higher titer
of the ALV-J challenge and improper administration route
may have impaired the interference ability of recombinant
plasmid. For clinical practice, the optimal RNAi condition
in vivo is needed to be further studied in future.
Conclusions
This study has demonstrated that miRNA embedded
siRNA method is an effective method to inhibit ALV-J
Figure 5 qPCR detection of single target and double target
interference efficiency. All four single recombinant vectors, p-miR-gag,
p-miR-pol, p-miR-env and p-miR-LTR, induced a significant reduction
in viral RNA copies of 83%, 78%, 85%, 74%, respectively. Combining
p-siR-LTR with p-siR-gag, p-siR-pol and p-siR-env showed more
significant reduction in viral RNA copies of 98%, 98% and 96%.
Single-target and double-target showed significantly difference (P < 0.05).
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miRNA-embedded siRNA showed more powerful inhibi-
tive effect than those of single target. The RNAi of
miRNA embedded siRNA has a potential value for clin-
ical application in poultry flocks.
Materials and methods
Virus, cells and animals
The animals used in this study were approved by the
Shandong Animal Care and Use Committee (SDACUC
number 14-095). The stock virus, NX0101 stain of ALV-
J, was isolated from in broiler breeder by our lab. The
virus titer was determined by limiting dilution in DF-1
culture. Briefly, DF-1 cells were seeded at 5 × 105 cells/
well of 6-well plate and infected the following day with
the NX0101 strain of ALV-J. Culture supernatants and
cells were collected at different time point postinfection
and stored at -80°C. Growth curve of the virus was mon-
itored by qPCR. DF-1 cell line, a continuous line of
chicken embryo fibroblasts, is derived from an EV-0 em-
bryo and is free of endogenous sequences related to the
avian sarcoma and leukosis virus (ALSV) group [28]. All
DF-1 cells were maintained in DMEM supplemented
with10% FBS. Day old of Leghorn SPF chickens (Saisi)
were used for in vivo RNAi experiment.
Design and production of pre-miRNA
The nucleotide sequences homology of NX0101 (subgroup
J, DQ115805) with MQNCSU (subgroup A, DQ365814),
SDAU09E3 (subgroup B, JF826241), RSV-Prague (subgroup
C, J02342), RSV-Schmidt-Ruppin D (subgroup D, D10652),
SD0501(subgroup E, EM467236), HPRS103 (subgroup J,
Z46390) and ADOL-7501 (subgroup J, AY027920) that ob-
tained from the National Center for Biotechnology Infor-
mation (NCBI) were analyzed using Clustal W Method of
the DNA Star software, selecting the highest homologytarget sequences. Furthermore, using software available
at http://rnaidesigner.lifetechnologies.com/rnaiexpress, four
RNA oligonucleotide sequences, gag (p15)-2477, pol (p32)-
4616, env (gp85)-6146 and LTR(U3)-7497, were selected
as target siRNA based on the homology information of
above ALV subgroup (Table 2). Each pre-miRNA se-
quence (Table 3) was designed as a single-stranded DNA
oligonucleotide, ~64 nt in length and encoding, in order:
sequence for 5′ overhang, a 21 nt target antisense siRNA
sequence; a mouse miR-155 loop; and the 19 nt sequence
deleted nucleotide No 9 and No10 of target sense siRNA
sequence, with a corresponding complementary single-
stranded DNA oligonucleotides. All pre-miNRA sequences
were synthesized by Invitrogen.
Construction of miRNA-embedded siRNA expression vectors
Two complementary oligonucleotides were denatured and
annealed into double-stranded DNAs, and then were
inserted into a linearized expression vector, pcDNA6.2-GW/
EmGFP-miR (Invitrogen). The pcDNA6.2-GW/EmGFP-
miR vectors had the BLOCK-iT Lentiviral Pol II miR RNAi
Expression Systems that were designed to express artificial
pre-miRNA hairpin which were excised by Drosha when
present in the nucleus. After excision, the pre-miRNA
hairpin is exported to the cytoplasm for further processing
by Dicer. One strand of the resulting miRNA duplex inter-
mediate is incorporated into RISC, where it acts as a
guide RNA to target RISC to fully complementary ALV-J
mRNAs. This primarily results in translational inhibition
and mRNA degradation. The expressed structure of miRNA-
embedded siRNA is shown in Figure 1B. All recombinant
plasmids were sequenced (F:5′- GGCATGGACGAGCTG
TACAA -3′; R: 5′- CTCTAGATCAACCACTTTGT -3′;
invitrogen) to confirm the inserted sequences are right.
Each recombinant plasmid was transformed into compe-
tent cell DH5α and smeared on LB solid medium contain-
ing 50 μg/ml of spectinomycin dihydrochloride (Sigma)
for amplification. The positive clones were propagated
and cultured in liquid LB. The recombinant plasmids were
extracted with endotoxin-free plasmid extraction kit (Sigma).
Recombinant vector transfection
DF-1 cells were seeded in 24-well plates (70% confluence)
and transfected with recombinant vectors (200 ng/well) by
using Lipofectamin 2000 (Invitrogen) according to the man-
ufacturer’s instructions. This concentration was determined
to be optimal in preliminary experimentation. At 48 h post
transfection, GFP expression from the vectors was detected
by fluorescence microscopy as described previous [14].
MiRNA-embedded siRNA inhibition assay for ALV-J
replication in vitro
Single target and double targets interference strategy
were used in vitro study. When DF-1 cells that infected
Table 1 p27 antigen of ALV-J shedding tested by ELISA
2d 4d 6d 8d 10d 12d 16d 20d 22d 24d 28d
normal control 0.04 ± 0.08 0.04 ± 0.17 0.02 ± 0.06 0.11 ± 0.10 0.03 ± 0.10 0.01 ± 0.06 0.02 ± 0.07 0.01 ± 0.01 0.07 ± 0.05 0.04 ± 0.04 0.07 ± 0.04
null control 0.26 ± 0.02 1.08 ± 0.08 0.46 ± 0.22 1.14 ± 0.21 1.25 ± 0.55 0.43 ± 0.06 1.73 ± 0.76 0.44 ± 0.21 0.86 ± 0.21 0.47 ± 0.24 1.33 ± 0.19
ALV-J control 0.57 ± 0.08 1.23 ± 0.05 0.99 ± 0.37 0.29 ± 0.12 1.43 ± 0.24 0.24 ± 0.09 1.12 ± 0.18 0.45 ± 0.37 1.26 ± 0.08 0.24 ± 0.11 1.36 ± 0.30
p-miR-gag + LTR 0.06 ± 0.08 0.09 ± 0.10 0.08 ± 0.12 0.05 ± 0.06 0.03 ± 0.07 0.08 ± 0.07 0.26 ± 0.10a 0.03 ± 0.07 0.05 ± 0.03 0.31 ± 0.17 0.43 ± 0.15
p-miR-pol + LTR 0.03 ± 0.01 0.02 ± 0.00 0.02 ± 0.00 0.03 ± 0.00 0.01 ± 0.00 0.04 ± 0.02 0.03 ± 0.08 0.02 ± 0.05 0.21 ± 0.08a 0.38 ± 0.06 0.19 ± 0.10
p-miR-env + LTR 0.03 ± 0.00 0.02 ± 0.00 0.02 ± 0.01 0.13 ± 0.00 0.02 ± 0.00 0.04 ± 0.03 0.14 ± 0.01 0.02 ± 0.02 0.33 ± 0.04a 0.37 ± 0.17 0.08 ± 0.13
p-miR-gag 0.04 ± 0.00 0.02 ± 0.00 0.06 ± 0.00 0.08 ± 0.01 0.17 ± 0.00 0.31 ± 0.04a 0.02 ± 0.07 0.22 ± 0.06 0.3 ± 0.08 0.02 ± 0.06 0.38 ± 0.23
p-miR-pol 0.05 ± 0.01 0.08 ± 0.01 0.12 ± 0.00 0.20 ± 0.00a 0.25 ± 0.01 0.02 ± 0.03 0.09 ± 0.01 0.01 ± 0.05 0.31 ± 0.13 0.22 ± 0.14 0.43 ± 0.15
p-miR-env 0.01 ± 0.01 0.01 ± 0.01 0.02 ± 0.00 0.01 ± 0.01 0.02 ± 0.00 0.15 ± 0.11 0.22 ± 0.06a 0.01 ± 0.05 0.01 ± 0.15 0.04 ± 0.05 0.32 ± 0.07
p-miR-LTR 0.04 ± 0.01 0.03 ± 0.01 0.04 ± 0.04 0.18 ± 0.01 0.29 ± 0.00a 0.22 ± 0.03 0.01 ± 0.06 0.11 ± 0.21 0.44 ± 0.06 0.32 ± 0.18 0.09 ± 0.11









Table 2 Sequence of target siRNA





Null control GTCTCCACGCGCAGTACATTT /
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they were transfected with the RNAi recombinant ex-
pression plasmid (single target, 200 ng/well or double
targets, 100 ng/per plasmid/well) using X-treme GENE
HP DNA Transfection Reagent. At 6 h post transfection,
culture media was aspirated and replenished with
DMEM containing serum and 2% peracetic acid (PAA).
At 48 h post transfection, transfection efficiency was de-
termined by the expression of green fluorescent protein
(GFP) observed under a fluorescence microscope. DF-1
cells were harvested at 72 h post transfection, and the
inhibitory effect was determined by IFA, qPCR andTable 3 Sequence of pre-miRNA of miRNA-embeded
siRNA






























TCCACGCGCAGTACATTTcwestern blot. The negative control and null vector con-
trol group were simultaneously analyzed.
MiRNA-embedded siRNA anti-ALV-J infection in vivo
Day-old of Leghorn SPF chicks were randomly divided
into ten groups, 10 chicks each group. Chicks were
inouculated with 100 μL 105.2 TCID50 ALV-J and recom-
binant plasmid (2.5 mg/per chick for single target;
1.25 + 1.25 mg/per chick for double-target) with Lipofec-
tamin TM2000 (Invitrogen) in peritoneal cavity, and
were breed for four weeks (Table 4). Infection status was
identified by ELISA for antibody and antigen test at
interval day. Briefly, serum samples from jugular vein
were tested for the presence of ALV-J antibodies and
cloaca swabs were tested for the presence of group spe-
cific antigen (p27). Viral loads in blood were detected by
quantitative real time RT-PCR (qPCR). Chickens were
necropsied at the termination of the experiment, and the
gross and histopathology lesions were observed.
Immunofluorescence assays (IFA)
DF-1 cells that infected by ALV-J were transfected with re-
combinant plasmid using the methods described above.
At 72 h post transfection, cells were fixed with ice-cold
40% ethanol and 60% acetone and incubated with the 1D4
monoclonal antibody against ALV-J (dilution, 1:1000) for
1 h at 37°C. The cells were washed three times (10 min
per wash) with phosphate-buffered saline (PBS) and incu-
bated with the secondary antibody, PE-labeled goat anti-
mouse IgG for 1 h at 37°C. After three washes with PBS,
the cells were covered with 50% glycerin and examined
under a fluorescence microscope.
Quantitative real time RT-PCR (qPCR) assay for viral mRNA
RNA of DF-1 was collected at 72 h and treated with
DNase I using the RNeasy kit according to manufac-
turer’s instructions (Qiagen). cDNA was prepared by Pri-
meScript Kit (TAKARA). Amplifications of target gene
of gp85 and chicken GAPDH sequences were carried
out in separate reactions using the primers as showed in
Table 5. PCR was done in 50 μL containing 25 μL 2×
PCR master mix (Promega), 2 μL cDNA, and primers at
2.5 pmol each for 5 min at 95°C followed by 35 cycles of
30s at 95°C, 30 s at 55°C and 30 s at 72°C. The predict
segments are 144 bp and 132 bp. The amplified products
were cloned into pMD18-T vector (Promega), and plasmid
DNA was expanded, purified and accurately quantified by
UV-light spectroscopy. Serial dilutions of the plasmid
were prepared (from 106 to 10−1 copies per reaction) and
used to build a standard curve for quantification.
qPCR was performed using reagents from the SYBR
Premix Ex Taq Kit (ROCHE). Amplification of target
gene or reference gene was done in 20 μL volume, con-
taining 10.4 μL SYBR Ex Taq (2×, containing ROX),
Table 4 Virus or vector inoculation dose of each group







Normal control 10 - -
Null control 10 100 2500
ALV-J control 10 100 -
p-miR-gag + p-miR-LTR 10 100 1250 + 1250
p-miR-pol + p-miR-LTR 10 100 1250 + 1250
p-miR-env + p-miR-LTR 10 100 1250 + 1250
p-miR-gag 10 100 2500
p-miR-pol 10 100 2500
p-miR-env 10 100 2500
p-miR-LTR 10 100 2500
Wei et al. Virology Journal  (2015) 12:45 Page 8 of 90.2 μL P1 (10 mmol/L), 0.2 μL P2 (10 mmol/L), 2 μL
cDNA; and 10.4 μL SYBR Ex Taq (2×, containing ROX),
0.4 μL S1(10 mmol/L), 0.4 μL S2(10 mmol/L), 2 μL
cDNA, respectively. Run in qPCR instrument using two-
step protocol: 95°C for 30 sec. 43 cycles were done with
denaturation at 95°C, for 5 sec, annealing at 60°C for
34 sec, and extension at 72°C for 13 sec. Check melt
curve profiles for fluorescent nucleic acid binding dye
detection and ensure that products are specific.
qPCR data were analyzed using the comparative Ct
method(△△Ct) [29]. Differences between the Ct values of
the target gene (env) and the internal control (△Ct = Ct
target-Ct internal control) were calculated to normalize
the differences in the amount of total cDNA added to
each reaction and the efficiency of the qPCR. The negative
control was used as a reference for each comparison. Dif-
ferences between the △CT of each env expression plasmid
and reference sample (△△Ct = (Ct target-Ct internal con-
trol) env plasmid-(Ct target-Ct internal control)NC) were
calculated. The expression level of the target gene could
be calculated by 2-△△Ct and the value stood for an n-fold
difference relative to the negative sample. Results are pre-
sented as the mean ± standard deviation(s).The T test was
performed using SPSS 13.0 statistical software. A P value
less than 0.05 was considered statistically significant.
Western blot
Transfected DF-1 cells were washed with phosphate-
buffered saline and then lysed in 2× Laemmli loadingTable 5 Primers used to amplify ALV-J genes
Target gene Primer sequence Product size(bp)
Env Forward TGCGTGCGTGGTTATTATTTC 144
Reverse AATGGTGAGGTCGCTGACTGT
GADPH Forward GAACATCATCCCAGCGTCCA 132
Reverse CGGCAGGTCAGGTCAACAACbuffer (Bio-RAD). Proteins were boiled for 5 min, and
then were separated by SDS-polyacrylamide gel electro-
phoresis (PAGE). After SDS-PAGE, the proteins were
transferred onto nitrocellulose membrane. The mem-
brane was stained with 2.5% fast green in 10% acetic acid
for 2 min to visualize blotted proteins. Destaining was
performed with 10% acetic acid for 10 min. The mem-
brane was blocked with 10% skim milk. The ALV-J SU
protein was detected using the 1D4 monoclonal anti-
body against ALV-J (dilution, 1:1000). For detection of
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a
monoclonal antibody (Ambion) was used at a dilution
of 1:4,000. Peroxidase-coupled secondary antibodies
directed against mouse immunoglobulin (Pierce) were
diluted 1:10,000.
Competing interests
None of the authors has any financial or personal relationships that could
inappropriately influence or bias the content of the paper.
Authors’ contributions
Conceived and designed the experiments: CZQ; Performed the experiments:
WRR, MXQ; Critical discussion and final approval of manuscript: WGH, GHJ,
LJZ, FLX. All authors read and approved the final manuscript.
Acknowledgements
The study was supported by grants from Natural Science Foundation of
China (No. 31372458), Shandong Modern Agricultural Technology & Industry
System (No. SDAIT-13-011-04), and Shandong Science and Technology
Project (2014GNC111013).
Author details
1College of Veterinary Medicine, Shandong Agricultural University, Tai’an
271018, China. 2Xiangya School of Medicine, Changsha 410013, China.
Received: 13 November 2014 Accepted: 9 March 2015
References
1. Payne LN, Brown SR, Bumstead N, Howes K, Frazier JA, Thouless ME. A novel
subgroup of exogenous avian leukosis virus in chickens. J Gen Virol.
1991;72:801–7.
2. Payne LN, Gillespie AM, Howes K. Myeloid leukemia and transmission of the
HPRS-103 strain of avian leukosis virus. Leukemia. 1992;6:1167–76.
3. Fadly AM, Payne LN. Leukosis/sarcoma group. In: Saif YM, Barnes HJ, Fadly
AM, Glisson JR, McDougald LR, Swayne DE, editors. Diseases of poultry. 11th
ed. Ames, IA: Iowa State University Press; 2003. p. 465–516.
4. Fadly AM, Smith EJ. Isolation and some characteristics of an isolate
associated with myeloid leukosis in meat-type chickens in the United States.
Avian Dis. 1999;43:391–400.
5. Xu B, Dong W, Yu C, He Z, Lv Y, Sun Y, et al. Occurrence of avian leukosis
virus subgroup J in commercial layer flocks in China. Avian Pathol.
2004;33:13–7.
6. Witter RL, Bacon LD, Hunt HD, Silva RF, Fadly AM. Avian leukosis virus
subgroup J infection profiles in broiler breeder chickens: association with
virus transmission to progeny. Avian Dis. 2000;44:913–31.
7. Gao YL, Liu W, Gao HL, Qi XL, Lin H, Wang XM, et al. Effective inhibition of
infectious bursal disease virus replication in vitro by DNA vector-based RNA
interference. Antivir Res. 2008;79:87–94.
8. Chen M, Payne WS, Henry H, Zhang HN, Sheri LH, Jerry BD. Inhibition of
Marek’s disease virus replication by retroviral vector-based RNA interference.
Virol. 2008;377:265–72.
9. Chen M, Payne WS, Dunn JR, Chang S, Zhang HM, Hunt HD, et al. Retroviral
delivery of RNA interference against Marek’s disease virus in vivo. Poultry
Sci. 2009;88:1373–80.
Wei et al. Virology Journal  (2015) 12:45 Page 9 of 910. Luke SL, Zhao YG, Lorraine PS, Lydia K, Venugopal N. Targeting Marek’s
disease virus by RNA interference delivered from a herpesvirus vaccine.
Vaccine. 2009;27:298–306.
11. Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with
RNA interference. Nature. 2004;431:371–8.
12. Stephanie EM, Norbert P. RNAi screening: new approaches, understandings,
and organisms. WIREs RNA. 2012;3:145–58.
13. Hu WY, Myers CP, Kilzer JM, Pfaff SL, Bushman FD. Inhibition of retroviral
pathogenesis by RNA interference. Curr Biol. 2002;12:1301–11.
14. Chen M, Granger AJ, VanBrocklin MW, Payne WS, Hunt H, Zhang HM, et al.
Inhibition of avian leukosis virus replication by vector-based RNA interference.
Virol. 2007;365:464–72.
15. Meng QW, Zhang ZP, Wang W, Tian J, Xiao ZG. Enhanced inhibition of
Avian leukosis virus subgroup J replication by multi-target miRNAs. Virol J.
2011;8:556–865.
16. Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, et al. Fatality
in mice due to oversaturation of cellular microRNA/short hairpin RNA
pathways. Nature. 2006;441:537–41.
17. Gu S, Jin L, Zhang Y, Huang Y, Zhang F, Valdmanis PN, et al. The loop
position of shRNAs and pre-miRNAs is critical for the accuracy of dicer
processing in vivo. Cell. 2012;151:900–11.
18. Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha–DGCR8 complex
in primary microRNA processing. Gene Dev. 2004;18:3016–27.
19. Zeng Y, Yi R, Cullen BR. Recognition and cleavage of primary microRNA
precursors by the nuclear processing enzyme Drosha. EMBO J. 2005;24:138–48.
20. Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs
exhibit strand bias. Cell. 2003;115:209–16.
21. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in
the assembly of the RNAi enzyme complex. Cell. 2003;115:199–208.
22. Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNA-directed nuclease
mediates post-transcriptional gene silencing in Drosophila cells. Nature.
2000;404:29–296.
23. Chung KH, Hart CC, Al-Bassam S, Avery A, Taylor J, Patel PD, et al. Polycistronic
RNA polymerase II expression vectors for RNA interference based on BIC/miR-155.
Nucleic Acids Res. 2006;34:e53.
24. Liu YP, Haasnoot J, Ter Brake O, Berkhout B, Konstantinova P. Inhibition of
HIV-1 by multiple siRNAs expressed from a single micro-RNA polycistron.
Nucleic Acids Res. 2008;36:2811–24.
25. Zeng Y, Wagner EJ, Cullen BR. Both natural and designed micro RNAs can
inhibit the expression of cognate mRNAs when expressed in human cells.
Mol Cell. 2002;9:1327–33.
26. Sun D, Melegari M, Sridhar S, Rogler CE, Zhu L. Multi-miRNA hairpin method
that improves gene knockdown efficiency and provides linked multi-gene
knockdown. Biotechniques. 2006;41:59–63.
27. Boudreau RL, Martins I, Davidson BL. Artificial microRNAs as siRNA shuttles:
improved safety as compared to shRNAs in vitro and in vivo. Mol Ther.
2009;17:169–75.
28. Martin H, Douglas NF, Ivan B, Jason SI, Peter KV. The DF-1 Chicken Fibroblast
Cell Line: transformation Induced by Diverse Oncogenes and Cell Death
Resulting from Infection by Avian Leukosis Viruses. Virol. 1998;248:295–304.
29. Kenneth JL, Thomas DS. Analysis of Relative Gene Expression Data Using
Real-Time Quantitative PCR and the 2-△△CT. Method. 2001;25:402–8.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
